This finding is supported by some elegant investigations from Hampel’s group [4,5], showing both a correlation of peripheral BACE1 with well-established AD markers (CSF Aβ and t-Tau), and with axonal degeneration and brain atrophy in individuals at high risk for AD. Here, BACE1 is linked to Alzheimer disease.